Tuning the Optical Properties of Sulfonylaniline Derivatives: Degeneracy Breaking of Benzene Orbitals and Linkage through Nodal Planes.

The orbital degeneracy of benzene rings is resolved by an asymmetric push-pull system in 2,6-bis(methylsulfonyl)aniline (BMeSA), in which the highest occupied molecular orbital (HOMO) is located at the 4-position, while the lowest unoccupied molecular orbital (LUMO) is located at a different position and has a nodal plane through the carbon atoms at the 1- and 4-positions. Therefore, the π-extension of BMeSA at the 4-position reveals a strong overlap in the HOMO and a minimal overlap in the LUMO. Consequently, π-extended BMeSA derivatives exhibit longer absorbance and emission wavelengths in the order of the electron-donating abilities of their substituents at the 4-position, which is based on a decrease in an absolute HOMO-level-dependent HOMO-LUMO gap in accordance with the nodal arrangement. Positive fluorescent solvatochromism with polarity-dependent decrease in fluorescent intensity was also observed. The biaryls exhibited more planar geometries in the excited state than in the ground state. The charge transfer mechanism, which can be described as node-induced intramolecular charge transfer (NICT), differs from the planar intramolecular charge transfer (PICT) and twisted intramolecular charge transfer (TICT).

Enhancement of Tumor Antigen-specific T-cell Responses by Immune Checkpoint Blockade in Human Papillomavirus-related Head and Neck Squamous Cell Carcinoma.

BACKGROUND/AIM: Human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) is clinically and immunologically distinct from HPV-negative HNSCC. Herein, we investigated the presence of tumor antigens HPV E6/E7 and wild-type p53-specific T-cell responses, and the impact of immune checkpoint blockade in patients with HPV-positive HNSCC. MATERIALS AND METHODS: Peripheral blood mononuclear cells (PBMCs) from patients with HPV-positive HNSCC were stimulated with HPV E6/E7 or wild-type p53-derived peptide mixture and evaluated using the interferon-γ enzyme-linked immunosorbent spot assay. Flow cytometry was performed to analyze the proportion of T-cell subsets and T cells expressing immune checkpoint molecules. RESULTS: HPV E6/E7-specific T cells were detected in 22 (95.7%) of 23 patients, whereas wild-type p53-specific T cells were detected in 3 (15.0%) of 20 patients. Seven (43.8%) of 16 patients exhibited wild-type p53-specific T-cell responses, as determined using whole proteins instead of peptides. Immune checkpoint blockade enhanced wild-type p53-specific T-cell responses in 9 (45.0%) of 20 patients. Flow cytometric analysis of PBMCs revealed that responders exhibiting enhanced wild-type p53-specific T-cell responses following immune checkpoint blockade had a significantly higher proportion of Ki-67+CD4+ T cells, Ki-67+CD8+ T cells, regulatory T cells, PD-1+CD4+ T cells, and TIM-3+CD4+ T cells than non-responders. CONCLUSION: Our findings indicate that tumor antigen-specific T cells are present in the peripheral blood of patients with HPV-positive HNSCC. Blockade of checkpoint pathways can enhance T-cell responses in certain patients, probably via activated T cells, Tregs, and/or exhausted CD4+ T cells.